Center for Health Security, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (Mss Potter and Kaushal); Association of Public Health Laboratories, Silver Spring, Maryland (Ms Wroblewski and Mr Becker); and Brown University School of Public Health, Providence, Rhode Island (Dr Nuzzo).
J Public Health Manag Pract. 2022;28(6):607-614. doi: 10.1097/PHH.0000000000001585. Epub 2022 Jul 28.
The ability to diagnose and screen for infection is an important component of the US COVID-19 response and is facilitated by public health laboratories (PHLs). Anecdotal media reports and limited case studies have described some of the challenges faced by PHLs during the pandemic, particularly initial challenges related to developing and deploying tests to PHLs, but there has not been a systematic evaluation of the experience of PHLs during the pandemic.
To document challenges and lessons learned experienced by local and state PHLs during the COVID-19 pandemic to support generation of best practices for current and future similar emergencies.
DESIGN, SETTING, AND PARTICIPANTS: From February to June 2021, researchers conducted 24 interviews with 68 leaders and staff representing 28 local and state PHLs across 27 states. Thematic analysis of interview content documented operational challenges and any identified solutions or preventive measures used or proposed.
Analysis identified the following themes regarding challenges faced among PHLs: strategic decision making and determining the mandate of the PHL; political interference by jurisdictional leadership; federal mismanagement of the emergency; regulatory challenges; managing partnerships with other laboratories; acquisition of appropriate supplies; insufficient information systems; acquiring and retaining workforce; and difficulty accessing sufficient funding.
Within the identified themes, key informants provided further elaboration regarding how PHLs experienced, evaded, or solved these challenges. In addition, PHLs described how challenges evolved throughout the course of the COVID-19 pandemic and made proposals regarding how challenges could be prevented or further addressed in the future by laboratories or other decision makers and stakeholders.
While fellow laboratories and political leadership may gain inspiration from creative solutions employed by PHLs, recognition of long-standing gaps related to funding, laboratory workforce, and consideration of laboratory needs in preparedness policies must be addressed for future large-scale outbreaks.
诊断和筛查感染的能力是美国 COVID-19 应对工作的重要组成部分,这得益于公共卫生实验室(PHL)。有媒体报道和有限的案例研究描述了 PHL 在大流行期间面临的一些挑战,特别是与向 PHL 开发和部署测试相关的最初挑战,但尚未对 PHL 在大流行期间的经验进行系统评估。
记录当地和州 PHL 在 COVID-19 大流行期间遇到的挑战和经验教训,为当前和未来类似紧急情况生成最佳实践提供支持。
设计、地点和参与者:2021 年 2 月至 6 月,研究人员对来自 27 个州的 28 个地方和州 PHL 的 68 名领导人和工作人员进行了 24 次访谈。对访谈内容的主题分析记录了运营挑战以及使用或提出的任何确定的解决方案或预防措施。
分析确定了 PHL 面临的以下挑战主题:战略决策和确定 PHL 的任务;司法领导的政治干预;联邦对紧急情况的管理不善;监管挑战;管理与其他实验室的伙伴关系;获取适当的用品;信息系统不足;获取和留住劳动力;以及难以获得足够的资金。
在所确定的主题中,主要信息提供者进一步阐述了 PHL 如何体验、规避或解决这些挑战。此外,PHL 还描述了这些挑战在 COVID-19 大流行期间的演变过程,并就实验室或其他决策者和利益相关者如何在未来预防或进一步解决这些挑战提出了建议。
虽然其他实验室和政治领导层可能会从 PHL 采用的创造性解决方案中获得灵感,但必须解决与资金、实验室劳动力以及在备灾政策中考虑实验室需求相关的长期差距,以便为未来的大规模疫情做好准备。